Adrian TE - Search Results

1

12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation.

Ding XZ, Tong WG, Adrian TE. Ding XZ, et al. Among authors: adrian te. Int J Cancer. 2001 Dec 1;94(5):630-6. doi: 10.1002/ijc.1527. Int J Cancer. 2001. PMID: 11745456

2

Early changes in islet hormone secretion in the hamster pancreatic cancer model.

Permert J, Herrington M, Kazakoff K, Pour PM, Adrian TE. Permert J, et al. Among authors: adrian te. Teratog Carcinog Mutagen. 2001;21(1):59-67. Teratog Carcinog Mutagen. 2001. PMID: 11135321

3

Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer.

Al Shemaili J, Mensah-Brown E, Parekh K, Thomas SA, Attoub S, Hellman B, Nyberg F, Adem A, Collin P, Adrian TE. Al Shemaili J, et al. Among authors: adrian te. Eur J Cancer. 2014 May;50(7):1391-8. doi: 10.1016/j.ejca.2014.01.002. Epub 2014 Jan 22. Eur J Cancer. 2014. PMID: 24462376

4

Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer.

Ding XZ, Tong WG, Adrian TE. Ding XZ, et al. Among authors: adrian te. Pancreatology. 2001;1(4):291-9. doi: 10.1159/000055827. Pancreatology. 2001. PMID: 12120207 Review.

5

Inhibition of pancreatic cancer cell growth.

Adrian TE. Adrian TE. Cell Mol Life Sci. 2007 Oct;64(19-20):2512-21. doi: 10.1007/s00018-007-7072-4. Cell Mol Life Sci. 2007. PMID: 17676272 Review.

6

BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation.

Hennig R, Osman T, Esposito I, Giese N, Rao SM, Ding XZ, Tong WG, Büchler MW, Yokomizo T, Friess H, Adrian TE. Hennig R, et al. Among authors: adrian te. Br J Cancer. 2008 Oct 7;99(7):1064-73. doi: 10.1038/sj.bjc.6604655. Epub 2008 Sep 9. Br J Cancer. 2008. PMID: 18781173 Free PMC article.

7

The role of oxygen-derived free radicals and nitric oxide in cytokine-induced antiproliferation of pancreatic cancer cells.

Thomas WJ, Thomas DL, Knezetic JA, Adrian TE. Thomas WJ, et al. Among authors: adrian te. Pancreas. 2002 Mar;24(2):161-8. doi: 10.1097/00006676-200203000-00007. Pancreas. 2002. PMID: 11854621

8

Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.

Tong WG, Ding XZ, Hennig R, Witt RC, Standop J, Pour PM, Adrian TE. Tong WG, et al. Among authors: adrian te. Clin Cancer Res. 2002 Oct;8(10):3232-42. Clin Cancer Res. 2002. PMID: 12374694

9

A novel anti-pancreatic cancer agent, LY293111.

Ding XZ, Talamonti MS, Bell RH Jr, Adrian TE. Ding XZ, et al. Among authors: adrian te. Anticancer Drugs. 2005 Jun;16(5):467-73. doi: 10.1097/00001813-200506000-00001. Anticancer Drugs. 2005. PMID: 15846111 Review.

10

Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway.

Yoshida S, Yokota T, Ujiki M, Ding XZ, Pelham C, Adrian TE, Talamonti MS, Bell RH Jr, Denham W. Yoshida S, et al. Among authors: adrian te. Biochem Biophys Res Commun. 2004 Oct 29;323(4):1241-5. doi: 10.1016/j.bbrc.2004.08.229. Biochem Biophys Res Commun. 2004. PMID: 15451430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results